Expand NEO Menu
NEO MENU

NEO Latest Press Releases

-- April 30, 2024 --

NeoGenomics Reports First Quarter 2024 Results Business Wire 7:30 AM

-- April 18, 2024 --

NeoGenomics Announces Senior Leadership Promotions Business Wire 7:05 AM

-- April 9, 2024 --

NeoGenomics to Report First Quarter 2024 Financial Results on April 30, 2024 Business Wire 7:00 AM

-- March 27, 2024 --

NeoGenomics Showcases Commitment to Transforming Cancer Patient Care at AACR 2024 Annual Meeting Business Wire 8:30 AM

-- March 20, 2024 --

NeoGenomics Releases Inaugural Environmental, Social, and Governance (ESG) Report Business Wire 7:00 AM

-- March 1, 2024 --

NeoGenomics to Participate in the TD Cowen 44th Annual Health Care Conference Business Wire 7:05 AM

-- February 20, 2024 --

NeoGenomics Reports Fourth Quarter and Full Year 2023 Results Business Wire 4:05 PM

-- February 1, 2024 --

NeoGenomics Signs Working with Cancer Pledge in Support of Employees Business Wire 7:05 AM

-- January 30, 2024 --

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of NeoGenomics, Inc. - NEO PRNewswire 7:45 PM
Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030 Globe Newswire 9:15 AM
NeoGenomics to Report Fourth Quarter and Full Year 2023 Financial Results on February 20, 2024 Business Wire 7:05 AM

-- January 26, 2024 --

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of NeoGenomics, Inc. - NEO Globe Newswire 12:29 PM

-- January 22, 2024 --

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of NeoGenomics, Inc. - NEO PRNewswire 7:20 PM

-- January 18, 2024 --

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of NeoGenomics, Inc. - NEO Globe Newswire 5:22 PM

-- January 14, 2024 --

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of NeoGenomics, Inc. - NEO PRNewswire 11:45 AM

-- January 10, 2024 --

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of NeoGenomics, Inc. - NEO Globe Newswire 3:17 PM

-- January 9, 2024 --

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of NeoGenomics, Inc. - NEO Pomlaw 3:29 PM

-- January 6, 2024 --

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of NeoGenomics, Inc. - NEO PRNewswire 11:15 AM

-- January 2, 2024 --

ROSEN, A LEADING NATIONAL FIRM, Encourages NeoGenomics, Inc. Investors to Inquire About Securities Class Action Investigation NEO Business Wire 5:16 PM
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of NeoGenomics, Inc. - NEO Globe Newswire 3:22 PM
NeoGenomics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference Business Wire 7:05 AM

-- December 29, 2023 --

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of NeoGenomics, Inc. - NEO PRNewswire 1:08 PM

-- December 28, 2023 --

NeoGenomics to Appeal Ruling ACCESSWIRE 8:10 AM

-- December 5, 2023 --

NeoGenomics to Present New Data at San Antonio Breast Cancer Symposium Highlighting Utility of RaDaR for Therapy Response ACCESSWIRE 8:01 AM